Pnc Financial Services Group, Inc. Chimerix Inc Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.1 - $1.54 $394 - $552	359 New	359 $0
Q2 2022 Aug 12, 2022	BUY	$1.34 - $5.34 $167 - $667	125 New	125 $0
Q1 2020 May 08, 2020	SELL	$1.27 - $2.33 $196 - $361	-155 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$1.3 - $2.72 $32 - $68	25 Added 19.23%	155 $0
Q3 2019 Nov 08, 2019	SELL	$1.93 - $4.21 $34 - $75	-18 Reduced 12.16%	130 $0
Q2 2018 Aug 10, 2018	BUY	$4.43 - $5.14 $655 - $760	148 New	148 $0

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.